Tag: Prescription Drugs
Rocatinlimab Effective for Moderate-to-Severe Atopic Dermatitis
Lasting improvement seen for patients receiving anti-OX40 antibody rocatinlimab compared with placebo
Drop in Mortality Seen With AChEI, Memantine in Dementia With Lewy Bodies
Risk for death, unplanned hospital admission significantly lower for those taking AChEIs only or taking AChEIs and memantine
SABCS: Interrupting Endocrine Therapy Does Not Pose Breast Cancer Recurrence Risk
Findings seen among young women with early-stage, hormone receptor-positive breast cancer desiring pregnancy
USPSTF Recommends PrEP for Reducing Risk for HIV Acquisition
Preexposure prophylaxis recommended for adolescents and adults at increased risk for acquiring HIV infection
Risk-Reducing Medications Can Cut Breast Cancer Death Rates
Tamoxifen with annual screening reduced invasive breast cancers and breast cancer deaths by 40 and 57 percent, respectively
Nirmatrelvir Plus Ritonavir Reduces Risks for COVID-19 in Seniors
Reduced risks for hospitalization and death observed for mainly vaccinated outpatients aged 50 years or older with COVID-19
Addition of Immunomodulators Cuts Vascular Inflammation in RA
Significant reduction in disease activity seen for patients receiving TNFi or triple therapy, with no difference between them
Fewer Buprenorphine Initiation Episodes Seen During Pandemic
Number of active buprenorphine episodes comparable to expected number, with fewer initiations and fewer ending of episodes
Viral Rebound Uncommon After Molnupiravir, Nirmatrelvir-Ritonavir Therapy
Viral rebound uncommon with treatment for patients hospitalized with COVID-19 and not associated with increased mortality
Recommendations Updated for Treatment, Prevention of HIV
Because people with HIV are living longer, management of comorbidities throughout the life span is increasingly important
